Search filters

List of works by Daniel Martin

Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy?

scientific article

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy

scientific article published on 14 August 2019

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy

scientific article published on 08 November 2019

Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer

scientific article published on 17 January 2018

Chemoradiotherapy for anal cancer: are we as good as we think?

scientific article published on 01 April 2019

Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy

scientific article published on 6 February 2017

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial

scientific article published on 02 April 2019

Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy

scientific article published on 31 December 2018

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer.

scientific article

Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy

scientific article published on 23 July 2016

Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.

scientific article published on 6 November 2017

The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.

scientific article

[How long should we wait upon completion of chemoradiotherapy before assessment of tumor response in anal cancer?]

scientific article published on 01 July 2017

Paulina is supported by:

About Paulina

Help